Búsqueda | Portal de Búsqueda de la BVS España

1.

An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer.

Brady, Joanne; Corrie, Pippa; Chau, Ian; Digumarti, Raghunadharao; Adams, Laurel M; Botbyl, Jeffrey; Laubscher, Kevin H; Midgley, Rachel S; Mallath, Mohandas.

Invest New Drugs; 31(5): 1228-35, 2013 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-23456563

2.

The emergence of 'omics for the management of colorectal cancer.

Midgley, Rachel S; Church, David; Kerr, David J.

Curr Opin Oncol; 23(4): 410-4, 2011 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-21577111

3.

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

Kerr, David J; Dunn, Janet A; Langman, Michael J; Smith, Justine L; Midgley, Rachel S J; Stanley, Andrew; Stokes, Joanne C; Julier, Patrick; Iveson, Claire; Duvvuri, Ravi; McConkey, Christopher C.

N Engl J Med; 357(4): 360-9, 2007 Jul 26.

Artículo en Inglés | MEDLINE | ID: mdl-17652651

4.

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.

Palmer, Daniel H; Midgley, Rachel S; Mirza, Noweeda; Torr, Elizabeth E; Ahmed, Forhad; Steele, Jane C; Steven, Neil M; Kerr, David J; Young, Lawrence S; Adams, David H.

Hepatology; 49(1): 124-32, 2009 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-18980227

5.

Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.

Hamdollah Zadeh, Maryam A; Amin, Elianna M; Hoareau-Aveilla, Coralie; Domingo, Enric; Symonds, Kirsty E; Ye, Xi; Heesom, Katherine J; Salmon, Andrew; D'Silva, Olivia; Betteridge, Kai B; Williams, Ann C; Kerr, David J; Salmon, Andrew H J; Oltean, Sebastian; Midgley, Rachel S; Ladomery, Michael R; Harper, Steven J; Varey, Alexander H R; Bates, David O.

Mol Oncol; 9(1): 167-78, 2015 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-25224594

6.

Ras as a target in cancer therapy.

Midgley, Rachel S; Kerr, David J.

Crit Rev Oncol Hematol; 44(2): 109-20, 2002 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-12413630

7.

Immunotherapy for colorectal cancer.

Midgley, Rachel S; Kerr, David J.

Expert Rev Anticancer Ther; 3(1): 63-78, 2003 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-12597351

8.

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.

Midgley, Rachel S; McConkey, Christopher C; Johnstone, Elaine C; Dunn, Janet A; Smith, Justine L; Grumett, Simon A; Julier, Patrick; Iveson, Claire; Yanagisawa, Yoko; Warren, Bryan; Langman, Michael J; Kerr, David J.

J Clin Oncol; 28(30): 4575-80, 2010 Oct 20.

Artículo en Inglés | MEDLINE | ID: mdl-20837956

9.

Evolution of nonsurgical therapy for colorectal cancer.

Midgley, Rachel S; Yanagisawa, Yoko; Kerr, David J.

Nat Clin Pract Gastroenterol Hepatol; 6(2): 108-20, 2009 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-19153564

10.

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.

Midgley, Rachel S; Kerr, David J.

J Clin Oncol; 31(12): 1611, 2013 Apr 20.

Artículo en Inglés | MEDLINE | ID: mdl-23509312

11.

Medical oncology: A novel low-toxicity regimen for advanced colorectal cancer?

Yanagisawa, Yoko; Midgley, Rachel S.

Nat Rev Clin Oncol; 7(10): 556-7, 2010 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-20877418

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer.

The emergence of 'omics for the management of colorectal cancer.

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.

Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.

Ras as a target in cancer therapy.

Immunotherapy for colorectal cancer.

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.

Evolution of nonsurgical therapy for colorectal cancer.

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.

Medical oncology: A novel low-toxicity regimen for advanced colorectal cancer?